Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease

• 主要な著者: V. I. Ignatyeva (著者), S. V. Moiseev (著者), N. M. Bulanov (著者), E. A. Karovajkina (著者), A S. Moiseev (著者)
• フォーマット: 図書
• 出版事項: IRBIS LLC, 2019-01-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Fabry disease (FD) is a severe lysosome storage disease caused by congenital deficiency of the enzyme α-galactosidase A and characterized by the risk of renal failure combined with cardiovascular and CNS complications. According to the currently available information, the early start of enzyme repla...